Today’s New York Times had a most distressing, but not surprising article, written by Reed Abelson, discussing the probable trend we will see in the near future in cancer treatment reimbursements. In a cost cutting experiment, the United Healthcare insurance company (UHC), will be starting a pilot project which entails paying medical oncology practices to [...]
It is again time to contact your members in congress and urge them to support of H.R. 6389 (the Prostate Act), which, if passed, would require coordination and intensification of prostate cancer research by government departments. The bill was introduced on Sept. 29 by the Rep. Edolphus Towns (D-NY), chair of the House Committee on [...]
Referring back to last Friday’s post asking that you share your comments on the ABC News Blog About the President’s failure to light the White House Blue, here are just a few of the many that were posted: Why politicize breast cancer? Every kind of cancer is horrible. Last month (September) was prostate cancer awareness [...]
I apologize for the lack of posts but I just returned from Virginia where I served as an ad hoc reviewer for U.S. Army Medical Research and Materiel Command (USAMRMC) Prostate Cancer Research Program (PCRP) aka the Congressionally Directed medical Research Program. We spent two very intensive days reviewing prostate cancer research grant applications from [...]
Expert opinion about the “three months to live” prognosis Scottish physicians gave Abdelbaset Ali Mohmed al-Megrahi in August 2009. September 29, 2010 “Based on the medical report issued by the Scottish authorities, I believe that three-month prognosis was medically unjustifiable. Any physician with any training or experience in treating prostate cancer would have known that [...]
President Obama finally declares September as National Prostate Cancer Month A PROCLAMATION Although its mortality rate has steadily fallen in the last decade, prostate cancer is still the second leading cause of cancer deaths among men in the United States. This year alone, nearly 218,000 men will be diagnosed with prostate cancer, and more than [...]
The Center for Medicare and Medicaid Services (CMS), the U.S. agency in charge of Medicare, announced yesterday that it has scheduled a meeting to discuss the coverage of Dendreon’s prostate cancer vaccine Provenge. The meeting has been scheduled for this November 17. […]
Have you had the experience of being given a different medication from the pharmacy than was prescribed by your doctor? Have you had the pharmacy switch your prescription, whether from a brand to a generic or to a different generic, or even to a different class of medication altogether? If you know of anybody who [...]
What is the real cost of approved treatments for advanced prostate cancer and how much we should spend? These questions are rippling through the prostate cancer community and the general population. […]
I know, we all have our prostate cancer story where we are told how lucky we are that we have prostate cancer. The conversation goes on something like, “Oh you are so lucky, you have the GOOD cancer, you should be so thankful.” Then it is often followed up by something like, “My (father) (brother) [...]
